CN103073475A - 1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 - Google Patents
1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 Download PDFInfo
- Publication number
- CN103073475A CN103073475A CN2013100476371A CN201310047637A CN103073475A CN 103073475 A CN103073475 A CN 103073475A CN 2013100476371 A CN2013100476371 A CN 2013100476371A CN 201310047637 A CN201310047637 A CN 201310047637A CN 103073475 A CN103073475 A CN 103073475A
- Authority
- CN
- China
- Prior art keywords
- boc
- reaction
- pyrrolin
- carboxyl compounds
- synthetic method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *N(CC1)CC1O Chemical compound *N(CC1)CC1O 0.000 description 3
- XIJONUDNIKEDEC-UHFFFAOYSA-N CC(C)(C)OC(N1C(C(O)=O)=CCC1)=O Chemical compound CC(C)(C)OC(N1C(C(O)=O)=CCC1)=O XIJONUDNIKEDEC-UHFFFAOYSA-N 0.000 description 1
- ABSPSSKCZNCXHQ-UHFFFAOYSA-N CCOC(C1=CCCN1C)=O Chemical compound CCOC(C1=CCCN1C)=O ABSPSSKCZNCXHQ-UHFFFAOYSA-N 0.000 description 1
- FLVFPAIGVBQGET-UHFFFAOYSA-N CN(CC1)CC1O Chemical compound CN(CC1)CC1O FLVFPAIGVBQGET-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100476371A CN103073475A (zh) | 2013-02-06 | 2013-02-06 | 1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100476371A CN103073475A (zh) | 2013-02-06 | 2013-02-06 | 1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103073475A true CN103073475A (zh) | 2013-05-01 |
Family
ID=48150196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100476371A Pending CN103073475A (zh) | 2013-02-06 | 2013-02-06 | 1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103073475A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115160205A (zh) * | 2022-07-08 | 2022-10-11 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101163472A (zh) * | 2005-04-21 | 2008-04-16 | 默克公司 | Vla-4拮抗剂 |
WO2012040242A1 (en) * | 2010-09-22 | 2012-03-29 | Intermune, Inc. | Substituted proline inhibitors of hepatitis c virus replication |
-
2013
- 2013-02-06 CN CN2013100476371A patent/CN103073475A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101163472A (zh) * | 2005-04-21 | 2008-04-16 | 默克公司 | Vla-4拮抗剂 |
WO2012040242A1 (en) * | 2010-09-22 | 2012-03-29 | Intermune, Inc. | Substituted proline inhibitors of hepatitis c virus replication |
Non-Patent Citations (6)
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115160205A (zh) * | 2022-07-08 | 2022-10-11 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
CN115160205B (zh) * | 2022-07-08 | 2024-06-07 | 上海皓鸿生物医药科技有限公司 | 一种制备(s)-1-(叔丁氧羰基)-2,5-二氢-1h-吡咯-2-羧酸及盐的方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104327119A (zh) | 磷酸泰地唑胺的制备方法 | |
CN104744334A (zh) | 维格列汀的制备方法 | |
CN102617434B (zh) | 一锅法制备维达列汀 | |
CN107540574B (zh) | R-联苯丙氨醇的制备方法 | |
EP3611163A1 (en) | High-purity isothiocyanate compound preparation method for industrial production | |
CN106749259A (zh) | 一种环戊基嘧啶并吡咯类化合物的合成方法 | |
CN103265482A (zh) | 博舒替尼的制备方法 | |
CN103073475A (zh) | 1-Boc-4,5-二氢吡咯-2-羧基类化合物的合成方法 | |
CN102002012A (zh) | 一种合成1,3-噁唑-2,4-二酮类化合物的方法 | |
CN102924548B (zh) | 卡培他滨的合成方法 | |
CN102936216B (zh) | 7,9-二氧代-2,6-氮杂-螺[3.5]壬-2-甲酸叔丁酯及其中间体的制备方法 | |
CN101921237B (zh) | 一种4-乙基-2,3-双氧代哌嗪-1-甲酸酯的制备方法 | |
CN104402813B (zh) | 一种索拉非尼的制备方法 | |
KR20230087479A (ko) | 신규한 중간체, 그 제조방법 및 용도 | |
CN102432616B (zh) | 一种制备l-脯氨酰胺及其中间体的方法 | |
CN109320510B (zh) | 一种马罗匹坦游离碱的制备方法 | |
CN103906747A (zh) | 卡巴他赛及其中间体的制备方法 | |
CN102174047A (zh) | 一种多尼培南的新型制备工艺 | |
CN106432043B (zh) | 2,3-吲哚二酮-3-n-烯基硝酮衍生物及其合成方法和应用 | |
CN101880285B (zh) | 一种烯丙基取代喜树碱化合物的合成方法 | |
CN102531985B (zh) | 一种制备依泽替米贝关键中间体的方法 | |
CN105712956B (zh) | 一种温和高效的多官能团取代环氧类化合物的制备方法 | |
CN104045646A (zh) | 三尖杉酯碱d环中间体合成方法 | |
CN103159705B (zh) | 卡巴他赛中间体的制备方法 | |
CN103408559A (zh) | 一种喜树碱及其衍生物的快速合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO Free format text: FORMER OWNER: TIANJIN YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. WUHAN YAOMING KANGDE NEW DRUGS DEVELOPMENT CO., LTD. YAOMINGKANGDE NEW MEDICINE DEVELOPMENT CO., LTD., WUXI SHANGHAI SYNTHEALL PHARMACEUTICAL CO., LTD. SHANGHAI STA PHARMACEUTICAL R + D CO., LTD. Effective date: 20141216 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141216 Address after: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant after: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant after: Wuhan AppTec New Drug Development Co., Ltd. Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Applicant before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Tianjin Yaoming Kangde New Medicine Development Co., Ltd. Applicant before: Wuhan AppTec New Drug Development Co., Ltd. Applicant before: Yaomingkangde New Medicine Development Co., Ltd., Wuxi Applicant before: Shanghai SynTheAll Pharmaceutical Co., Ltd. Applicant before: Shanghai STA Pharmaceutical R & D Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130501 |
|
WD01 | Invention patent application deemed withdrawn after publication |